AAAAAA

   
Results: 1-12 |
Results: 12

Authors: BAZZINO O BARRERO C GARRE L SOSA A AYLWARD P SLANY J BEAUDRY P BEDARD J DELAROCHELLIERE R NGUYEN M BOGATY P BOUDREAULT JR DIODATI JG DUPUIS J FITCHETT D FUNG A GERVAIS P GOSSARD D GRANDMONT D HUYNH T KOUZ S LANGER A LARAMEE P LEMAY M MAILLETTE S MARANDA C NASMITH J PESANT Y PHANUEF D PROULX G RUEL M THOMPSON C CORBALAN R BOTERO R HUSTED S HEIKKILA J CHARBONNIER B MOGUEL R COMMERFORD P LANDLESS P WEICH D MARITZ F MARX J FERNANDES F LIDON R SANZ G BOSCH X MOCCETTI T ALI N ANDERSON HV BAJWA T BORZAK S BOYEK T BREWER D CAMBIER P CHIVUKULA S CORDER C EZEKOWITZ M FELDMAN R GLICKMAN L JANG IK KLEIN M KORN D KRAUS S KWAN T MANN JT MARSHALL J MARTIN J MONRAD ES MUELLER H PENNY W SCHMEDTJE J STRONY J ARMSTRONG P DECANI J HIRSH J PEPINE C RYAN TJ THEROUX P CATELLALAWSON F DIODATI J ROY L WILLERSON JT YUSUF S ZHAO X SAX FL HARRIS KH PELLETIER G DAVIES R FLATHER M GOSSELIN G HERRMANN H KELLS C KNUDTSON M THADANI U SNAPINN SM GHANNAM A HAGGERT B WATSON A LIS J BRANCATO C FONG D
Citation: O. Bazzino et al., INHIBITION OF THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR WITH TIROFIBAN IN UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL-INFARCTION/, The New England journal of medicine, 338(21), 1998, pp. 1488-1497

Authors: CATELLALAWSON F KAPOOR S MORETTI DT COMBE S NICOLAS S DOREY S RORER RP THEROUX P FITZGERALD GA
Citation: F. Catellalawson et al., CHRONIC ORAL GLYCOPROTEIN IIB IIIA ANTAGONISM IN PATIENTS WITH UNSTABLE CORONARY SYNDROMES - REDUCED ANTIPLATELET EFFECT IN COMPARISON TO PATIENTS WITH STABLE CORONARY-ARTERY DISEASE/, Circulation, 98(17), 1998, pp. 1304-1304

Authors: BAUGHMAN RA KAPOOR SC AGARWAL RK KISICKI J CATELLALAWSON F FITZGERALD GA
Citation: Ra. Baughman et al., ORAL DELIVERY OF ANTICOAGULANT DOSES OF HEPARIN - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY IN HUMANS, Circulation, 98(16), 1998, pp. 1610-1615

Authors: CATELLALAWSON F
Citation: F. Catellalawson, DIRECT THROMBIN INHIBITORS IN CARDIOVASCULAR-DISEASE, Coronary artery disease, 8(2), 1997, pp. 105-111

Authors: CATELLALAWSON F KAPOOR S SKAMMER W FITZGERALD DJ ROCCA B TAMBY JF FITZGERALD GA
Citation: F. Catellalawson et al., CHRONIC INHIBITION OF THE PLATELET GLYCOPROTEIN IIB IIIA BY A NEW ORAL-AGENT - A DOSE-ESCALATION STUDY IN PATIENTS WITH CORONARY-ARTERY DISEASE (CAD)/, Thrombosis and haemostasis, 1997, pp. 1602-1602

Authors: MCADAM BF KAPOOR S CATELLALAWSON F FITZERALD GA
Citation: Bf. Mcadam et al., SELECTIVE-INHIBITION OF MONOCYTE COX-2 VS PLATELET COX-1 IN HUMANS, Circulation, 96(8), 1997, pp. 3117-3117

Authors: CATELLALAWSON F FITZGERALD GA
Citation: F. Catellalawson et Ga. Fitzgerald, TRIALS IN MYOCARDIAL-INFARCTION - RESPONSE, Circulation, 96(10), 1997, pp. 3815-3816

Authors: CATELLALAWSON F FITZGERALD GA
Citation: F. Catellalawson et Ga. Fitzgerald, CONFUSION IN REPERFUSION - PROBLEMS IN THE CLINICAL DEVELOPMENT OF ANTITHROMBOTIC DRUGS, Circulation, 95(4), 1997, pp. 793-795

Authors: BENNETT JS VILAIRE G CATELLALAWSON F RUT AR FITZGERALD G
Citation: Js. Bennett et al., THE PIA2 ALLOANTIGEN DOES NOT ALTER THE AFFINITY OF GPIIB-IIIA FOR FIBRINOGEN OR RGD-CONTAINING PEPTIDES, Blood, 90(10), 1997, pp. 676-676

Authors: CATELLALAWSON F KAPOOR S PRATICO D BRAUNSTEIN SN CARABALLO V FITZGERALD GA
Citation: F. Catellalawson et al., OXIDATIVE STRESS AND DIABETES-MELLITUS, Journal of investigative medicine, 44(3), 1996, pp. 223-223

Authors: CATELLALAWSON F FITZGERALD GA
Citation: F. Catellalawson et Ga. Fitzgerald, OXIDATIVE STRESS AND PLATELET ACTIVATION IN DIABETES-MELLITUS, Diabetes research and clinical practice, 30, 1996, pp. 13-18

Authors: CATELLALAWSON F FITZGERALD GA
Citation: F. Catellalawson et Ga. Fitzgerald, LONG-TERM ASPIRIN IN THE PREVENTION OF CARDIOVASCULAR DISORDERS - RECENT DEVELOPMENTS AND VARIATIONS ON A THEME, Drug safety, 13(2), 1995, pp. 69-75
Risultati: 1-12 |